Literature DB >> 25610059

The protective effect of dehydroepiandrosterone on ovarian tissues after torsion-detorsion injury: a stereological and histopathological study.

Bunyamin Borekci1, Cemal Gundogdu2, B Zuhal Altunkaynak3, Muhammed Calık2, M Eyup Altunkaynak3, Deniz Unal3, Bunyami Unal3.   

Abstract

OBJECTIVE: Ovarian torsion is a rare problem in pre-pubescent girls that must be included in the differential diagnosis of patients with abdominal or pelvic pain. Current advice for treatment to support ovary preservation considers the macroscopic appearance of the ovary, but this is not a reliable indicator of the degree of injury in cases of ovarian torsion. The aim of this study was to determine the effects of dehydroepiandrosterone (DHEA) treatment on the rat ovary after torsion-detorsion injury using a histopathological approach and stereological methods.
MATERIALS AND METHODS: Fifteen adult female Sprague Dawley rats were divided into three groups: sham operated (Control; n=5), torsion-detorsion with saline (Saline; n = 5), and torsion-detorsion with DHEA (DHEA; n = 5). Rats in the sham-operated group underwent a surgical procedure similar to the other groups, but the adnexa were not torsioned. The DHEA group was injected intraperitoneally 3 hours before detorsion and saline was administered to the saline group. After 24 h of adnexal detorsion, the rats in all groups were sacrificed and the adnexa were removed. The volume of ovarian stroma and edema were estimated using the Cavalieri Principle and were applied to serial paraffin sections. Ovary sections were also evaluated histopathologically.
RESULTS: The volume of ovarian edema was 35.4% lower in the saline group compared to the control group (p> 0.05). The volume of ovarian edema increased by 73.4% in the DHEA group (p<0.05). In the experimental groups, stromal volume was 41.0% higher in the saline group and 52% higher in the DHEA group in comparison to the control group. Statistically significant differences were found when comparing the volume of both ovarian edema and stroma between experimental groups (Detorsion/Saline group - Detorsion/DHEA group; p< 0.01). Histopathologically, mononuclear cell infiltration and vascular dilatation, perivascular edema and common necrotic changes were obvious in the torsion-detorsion damaged ovary. These changes were partially ameliorated by DHEA treatment.
CONCLUSIONS: The present study shows that administration of DHEA has beneficial effects in the prevention of ischemia-reperfusion injuries of the ovaries.

Entities:  

Keywords:  Cavalieri Principle; DHEA; Histopathology; Ovarian torsion; Stereology

Year:  2009        PMID: 25610059      PMCID: PMC4261661     

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  28 in total

1.  Unbiased estimation of the liver volume by the Cavalieri principle using magnetic resonance images.

Authors:  Bünyamin Sahin; Mehmet Emirzeoglu; Ahmet Uzun; Lütfi Incesu; Yüksel Bek; Sait Bilgic; Süleyman Kaplan
Journal:  Eur J Radiol       Date:  2003-08       Impact factor: 3.528

2.  Early diagnosis of ovarian torsion by color Doppler ultrasonography.

Authors:  B J Van Voorhis; J Schwaiger; C H Syrop; F K Chapler
Journal:  Fertil Steril       Date:  1992-07       Impact factor: 7.329

3.  Treatment of twisted ischemic adnexa by simple detorsion.

Authors:  J Shalev; M Goldenberg; G Oelsner; Z Ben-Rafael; D Bider; J Blankstein; S Mashiach
Journal:  N Engl J Med       Date:  1989-08-24       Impact factor: 91.245

4.  Recovery of ovarian function after laparoscopic treatment of acute adnexal torsion. A case report.

Authors:  T Vancaillie; E H Schmidt
Journal:  J Reprod Med       Date:  1987-07       Impact factor: 0.142

5.  Laparoscopic surgery in 12 cases of adnexal disease occurring in girls aged 15 years or younger.

Authors:  Akihiro Takeda; Shuichi Manabe; Satoyo Hosono; Hiromi Nakamura
Journal:  J Minim Invasive Gynecol       Date:  2005 May-Jun       Impact factor: 4.137

6.  Torsion of the ovary: sonographic features.

Authors:  M Graif; J Shalev; S Strauss; S Engelberg; S Mashiach; Y Itzchak
Journal:  AJR Am J Roentgenol       Date:  1984-12       Impact factor: 3.959

7.  [Morin in the therapy of the ischemia-reperfusion damage model of the rat kidney].

Authors:  L Bartosíková; J Necas; V Suchý; D Jankovská; E Janostíková; T Bartosík; J Klusáková; J Jurica; T Florian; M Frydrych; J Krcmár; P Frána; J Fránová
Journal:  Ceska Slov Farm       Date:  2006-03

8.  Dehydroepiandrosterone administration prevents the oxidative damage induced by acute hyperglycemia in rats.

Authors:  M Aragno; E Brignardello; E Tamagno; V Gatto; O Danni; G Boccuzzi
Journal:  J Endocrinol       Date:  1997-11       Impact factor: 4.286

9.  Dehydroepiandrosterone protects tissues of streptozotocin-treated rats against oxidative stress.

Authors:  M Aragno; E Tamagno; V Gatto; E Brignardello; S Parola; O Danni; G Boccuzzi
Journal:  Free Radic Biol Med       Date:  1999-06       Impact factor: 7.376

10.  Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats.

Authors:  M Aragno; S Parola; E Brignardello; A Mauro; E Tamagno; R Manti; O Danni; G Boccuzzi
Journal:  Diabetes       Date:  2000-11       Impact factor: 9.461

View more
  3 in total

1.  Does progesterone have protective effects on ovarian ischemia-reperfusion injury?

Authors:  Banu Güleç Başer; Mine İslimye Taşkın; Ertan Adalı; Emine Öztürk; Adnan Adil Hısmıoğulları; Arzu Yay
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-03-16

2.  Protective role of Proanthocyanidin in experimental ovarian torsion.

Authors:  Şule Yıldırım; Naci Topaloğlu; Mustafa Tekin; Adem Küçük; Havva Erdem; Mesut Erbaş; Ahmet Yıldırım
Journal:  Med J Islam Repub Iran       Date:  2015-02-23

3.  Effect of metformin and detorsion treatment on serum anti-Müllerian hormonelevels and ovarian histopathology in a rat ovarian torsion model

Authors:  Sema Karakaş; Cihan Kaya; Hakan Güraslan; Damlanur Sakiz; Sema Süzen Çaypinar; Hüseyin Cengiz; Murat Ekin; Levent Yaşar
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.